US Archives - Page 14 of 215 - European Medical Journal

ASCO congress Wrap 2026

ASCO 2026 Congress Wrap

The American Society of Clinical Oncology (ASCO) Annual Meeting 2026 was held in Chicago, Illinois, bringing together oncology experts from across the globe…

Clinician reviewing remote monitoring data for a patient recovering after sepsis hospitalization

Remote Monitoring Fails to Reduce Readmissions After Sepsis

Remote monitoring did not reduce readmissions after sepsis or lower respiratory tract infection, trial data show.

Andes hantavirus particle representing single-dose mRNA vaccine research.

Vaccine Breakthrough Targets Andes Hantavirus

Single-dose mRNA vaccines fully protected hamsters against Andes hantavirus, supporting faster outbreak-response vaccine development efforts.

Clinician reviewing biologic safety data related to Candida infections with secukinumab.

Secukinumab Candida Risk Emerges Early in Treatment

Candida infections linked to secukinumab were uncommon but often serious, with risk clustering early after treatment.

Clinician assessing hand and wrist trauma follow-up as attrition rates are reviewed in clinical trials.

Hand Injuries Carry Growing Social Burden

Hand and wrist trauma trials may face avoidable attrition that weakens evidence for patient care.

Patient discussing breast cancer quality of life and weight loss intervention with oncology clinician.

ASCO 2026: Weight Loss Intervention Boosts Breast Cancer QoL

Weight loss intervention improved breast cancer quality of life and symptoms in BWEL results presented at ASCO 2026.

Older adult after a fall on stairs, illustrating mild traumatic brain injury assessment.

Mild Traumatic Brain Injury Diagnosis Gets Biomarker Boost

Plasma biomarkers may improve mild traumatic brain injury diagnosis in older adults when symptoms and imaging are unclear.

Rheumatology nurses discussing automatic substitution of biological medicines with a patient in a clinical setting.

Rheumatology Nurses Support Automatic Biologic Substitution

Automatic substitution of biological medicines may be safe when pharmacy changes include counseling and care coordination.

Physician reviewing localized prostate cancer treatment outcomes and healthcare costs with a patient.

High-Risk Prostate Cancer Drives Poorer Outcomes And Higher Costs

Localized prostate cancer risk stratification predicted poorer survival and higher healthcare costs after radical prostatectomy.

11 Jun 2026

HRD Testing in Advanced Ovarian Cancer

Explore how HRD testing can help identify patients with HRD-positive advanced ovarian cancer who are eligible for certain targeted therapies.